377 related articles for article (PubMed ID: 25913517)
21. Controlled-releasing hydrogen sulfide donor based on dual-modal iron oxide nanoparticles protects myocardial tissue from ischemia-reperfusion injury.
Wang W; Liu H; Lu Y; Wang X; Zhang B; Cong S; Zhao Y; Ji M; Tao H; Wei L
Int J Nanomedicine; 2019; 14():875-888. PubMed ID: 30787606
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of hydrogen sulfide in a rat model of traumatic brain injury via activation of mitochondrial adenosine triphosphate-sensitive potassium channels and reduction of oxidative stress.
Jiang X; Huang Y; Lin W; Gao D; Fei Z
J Surg Res; 2013 Oct; 184(2):e27-35. PubMed ID: 23590867
[TBL] [Abstract][Full Text] [Related]
23. Role of Hydrogen Sulfide in Chronic Diseases.
Yang N; Liu Y; Li T; Tuo Q
DNA Cell Biol; 2020 Feb; 39(2):187-196. PubMed ID: 31895585
[TBL] [Abstract][Full Text] [Related]
24. Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics.
Wallace JL; Blackler RW; Chan MV; Da Silva GJ; Elsheikh W; Flannigan KL; Gamaniek I; Manko A; Wang L; Motta JP; Buret AG
Antioxid Redox Signal; 2015 Feb; 22(5):398-410. PubMed ID: 24635322
[TBL] [Abstract][Full Text] [Related]
25. Hydrogen sulfide-mediated myocardial pre- and post-conditioning.
Predmore BL; Lefer DJ
Expert Rev Clin Pharmacol; 2011 Jan; 4(1):83-96. PubMed ID: 21373204
[TBL] [Abstract][Full Text] [Related]
26. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes.
Pan TT; Feng ZN; Lee SW; Moore PK; Bian JS
J Mol Cell Cardiol; 2006 Jan; 40(1):119-30. PubMed ID: 16325198
[TBL] [Abstract][Full Text] [Related]
27. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels.
Johansen D; Ytrehus K; Baxter GF
Basic Res Cardiol; 2006 Jan; 101(1):53-60. PubMed ID: 16328106
[TBL] [Abstract][Full Text] [Related]
28. Sirtuin 6 is essential for sodium sulfide-mediated cytoprotective effect in ischemia/reperfusion-stimulated brain endothelial cells.
Hu Y; Li R; Yang H; Luo H; Chen Z
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):601-9. PubMed ID: 25543188
[TBL] [Abstract][Full Text] [Related]
29. Novel insights into hydrogen sulfide--mediated cytoprotection.
Calvert JW; Coetzee WA; Lefer DJ
Antioxid Redox Signal; 2010 May; 12(10):1203-17. PubMed ID: 19769484
[TBL] [Abstract][Full Text] [Related]
30. Controllable thioester-based hydrogen sulfide slow-releasing donors as cardioprotective agents.
Yao H; Luo S; Liu J; Xie S; Liu Y; Xu J; Zhu Z; Xu S
Chem Commun (Camb); 2019 May; 55(44):6193-6196. PubMed ID: 31070620
[TBL] [Abstract][Full Text] [Related]
31. Potential importance of alterations in hydrogen sulphide (H2S) bioavailability in diabetes.
Lefer DJ
Br J Pharmacol; 2008 Nov; 155(5):617-9. PubMed ID: 18806820
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis, and Cardioprotective Effects of N-Mercapto-Based Hydrogen Sulfide Donors.
Zhao Y; Yang C; Organ C; Li Z; Bhushan S; Otsuka H; Pacheco A; Kang J; Aguilar HC; Lefer DJ; Xian M
J Med Chem; 2015 Sep; 58(18):7501-11. PubMed ID: 26317692
[TBL] [Abstract][Full Text] [Related]
33. Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy.
Sun HJ; Wu ZY; Cao L; Zhu MY; Liu TT; Guo L; Lin Y; Nie XW; Bian JS
Molecules; 2019 Aug; 24(15):. PubMed ID: 31390847
[TBL] [Abstract][Full Text] [Related]
34. Role of hydrogen sulfide in secondary neuronal injury.
Wang JF; Li Y; Song JN; Pang HG
Neurochem Int; 2014 Jan; 64():37-47. PubMed ID: 24239876
[TBL] [Abstract][Full Text] [Related]
35. Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease.
Li Z; Polhemus DJ; Lefer DJ
Circ Res; 2018 Aug; 123(5):590-600. PubMed ID: 30355137
[TBL] [Abstract][Full Text] [Related]
36. Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments.
Chan MV; Wallace JL
Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G467-73. PubMed ID: 23868410
[TBL] [Abstract][Full Text] [Related]
37. The role of hydrogen sulfide in cyclic nucleotide signaling.
Cao X; Wu Z; Xiong S; Cao L; Sethi G; Bian JS
Biochem Pharmacol; 2018 Mar; 149():20-28. PubMed ID: 29158149
[TBL] [Abstract][Full Text] [Related]
38. [Effects of stimulation and blockade of the synthesis of endogenous hydrogen sulfide at myocardial ischemia-reperfusion].
Sahach VF; Shymans'ka TV; Hoshovs'ka IuV
Fiziol Zh (1994); 2013; 59(4):8-15. PubMed ID: 24175471
[TBL] [Abstract][Full Text] [Related]
39. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes.
Bian JS; Yong QC; Pan TT; Feng ZN; Ali MY; Zhou S; Moore PK
J Pharmacol Exp Ther; 2006 Feb; 316(2):670-8. PubMed ID: 16204473
[TBL] [Abstract][Full Text] [Related]
40. Hydrogen sulfide and renal ischemia.
Liu YH; Lu M; Bian JS
Expert Rev Clin Pharmacol; 2011 Jan; 4(1):49-61. PubMed ID: 22115348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
